• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤恶性黑色素瘤的免疫组织化学分析:S-100蛋白、HMB-45单克隆抗体和NKI/C3单克隆抗体的比较

Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.

作者信息

Fernando S S, Johnson S, Bäte J

机构信息

Department of Anatomical Pathology, South Western Area Pathology Service, Liverpool Hospital, New South Wales.

出版信息

Pathology. 1994 Jan;26(1):16-9. doi: 10.1080/00313029400169021.

DOI:10.1080/00313029400169021
PMID:8165017
Abstract

Immunohistochemical analysis was carried out on 144 formalin fixed paraffin embedded cutaneous melanomas to ascertain the value of 3 different immune markers. The sensitivity and staining patterns regarding intensity and distribution, as well as correlation to pigment content, cell type, surface ulceration and host response was noted. The stains used were monoclonal HMB-45 (Dako product No M634), NKI/C3 antibodies (Biogenex product No MU077) and polyclonal rabbit anti S-100A protein (Dako product No L1845). Of the lesions tested, 63 were malignant melanoma with an adjacent component of superficial spreading type, 61 were malignant melanoma with no adjacent component, 2 were malignant melanoma with adjacent lentigo maligna, 8 were in situ with 7 superficial spreading melanoma and one lentigo maligna (HMF) and 10 were metastatic melanoma. All 144 lesions stained for S-100 (100% sensitivity). One hundred and thirty-seven stained for NKI/C3 (95%); 132 stained for HMB-45 (92% sensitivity). S-100 was the most sensitive marker and stained tumor cells diffusely. With HMB-45 and NKI/C3, though marginally less sensitive, staining was stronger and patchy. In addition, NKI/C3 showed a tendency for peripheral (membrane) staining. HMB-45 staining was directly proportional to the pigment content, with stronger staining of radial growth phase melanoma and negative staining of those lesions where pigment content was minimal or absent. Also, with HMB-45 a decrease in staining intensity with depth or vertical growth phase was observed. There was no relationship to cell type with HMB-45 but with NKI/C3, 5 out of the 7 that failed to stain showed spindle cell differentiation.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对144例福尔马林固定石蜡包埋的皮肤黑色素瘤进行免疫组织化学分析,以确定3种不同免疫标志物的价值。记录了关于强度和分布的敏感性及染色模式,以及与色素含量、细胞类型、表面溃疡和宿主反应的相关性。所用染色剂为单克隆HMB-45(达科产品编号M634)、NKI/C3抗体(生物基因公司产品编号MU077)和多克隆兔抗S-100A蛋白(达科产品编号L1845)。在检测的病变中,63例为恶性黑色素瘤伴浅表扩散型相邻成分,61例为无相邻成分的恶性黑色素瘤,2例为伴有相邻恶性雀斑样痣的恶性黑色素瘤,8例为原位病变,其中7例为浅表扩散性黑色素瘤和1例恶性雀斑样痣(HMF),10例为转移性黑色素瘤。所有144个病变S-100染色均呈阳性(敏感性100%)。137个病变NKI/C3染色呈阳性(95%);132个病变HMB-45染色呈阳性(敏感性92%)。S-100是最敏感的标志物,肿瘤细胞呈弥漫性染色。HMB-45和NKI/C3虽然敏感性略低,但染色更强且呈斑片状。此外,NKI/C3显示出外周(膜)染色的倾向。HMB-45染色与色素含量直接相关,放射状生长期黑色素瘤染色更强,色素含量极少或无色素的病变染色为阴性。此外,观察到HMB-45染色强度随深度或垂直生长期降低。HMB-45与细胞类型无关,但NKI/C3染色阴性的7个病变中有5个显示梭形细胞分化。(摘要截断于250字)

相似文献

1
Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.皮肤恶性黑色素瘤的免疫组织化学分析:S-100蛋白、HMB-45单克隆抗体和NKI/C3单克隆抗体的比较
Pathology. 1994 Jan;26(1):16-9. doi: 10.1080/00313029400169021.
2
HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.转移性黑色素瘤中的HMB - 45、S - 100、NK1/C3和MART - 1
Hum Pathol. 2004 Feb;35(2):217-23. doi: 10.1016/j.humpath.2003.09.019.
3
Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma.皮肤恶性黑色素瘤中黑素细胞分化抗原的免疫组织化学研究。六种商业抗体与一种非商业抗体在结节性黑色素瘤、浅表扩散性黑色素瘤和恶性雀斑样痣黑色素瘤中的比较。
Cesk Patol. 2004 Apr;40(2):50-6.
4
The immunohistochemical identification of human oral mucosal melanocytes.人口腔黏膜黑素细胞的免疫组织化学鉴定
Arch Oral Biol. 1997 Jan;42(1):77-81. doi: 10.1016/s0003-9969(96)00113-6.
5
Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.恶性黑色素瘤中的上皮标志物。原发性病变及其转移灶的研究。
Am J Dermatopathol. 1994 Jun;16(3):241-6. doi: 10.1097/00000372-199406000-00003.
6
Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum.肾血管平滑肌脂肪瘤:对不断扩展的形态学谱进行进一步免疫表型特征分析。
Arch Pathol Lab Med. 2001 Jun;125(6):751-8. doi: 10.5858/2001-125-0751-RA.
7
Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
Pol J Pathol. 1995;46(3):167-72.
8
[Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].[单克隆抗体HMB45在黑色素瘤组织病理学诊断中的作用]
Ann Dermatol Venereol. 1990;117(10):691-9.
9
Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors.单克隆抗体HMB-45对恶性黑色素瘤的识别。200例石蜡包埋皮肤肿瘤的免疫组织化学研究。
J Cutan Pathol. 1988 Aug;15(4):201-7. doi: 10.1111/j.1600-0560.1988.tb00544.x.
10
Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.结膜和葡萄膜恶性黑色素瘤的免疫组织化学诊断:新型抗黑素A抗体与S100蛋白及HMB-45的比较
Melanoma Res. 2000 Aug;10(4):350-4. doi: 10.1097/00008390-200008000-00006.

引用本文的文献

1
Management of undifferentiated adrenal gland metastases from malignant melanoma: case report.恶性黑色素瘤所致未分化肾上腺转移瘤的治疗:病例报告
Front Oncol. 2024 Aug 20;14:1419827. doi: 10.3389/fonc.2024.1419827. eCollection 2024.
2
Generation of metastatic melanoma specific antibodies by affinity purification.通过亲和纯化生成转移性黑色素瘤特异性抗体。
Sci Rep. 2016 Nov 17;6:37253. doi: 10.1038/srep37253.
3
Investigation of cAMP microdomains as a path to novel cancer diagnostics.将环磷酸腺苷(cAMP)微区作为新型癌症诊断途径的研究。
Biochim Biophys Acta. 2014 Dec;1842(12 Pt B):2636-45. doi: 10.1016/j.bbadis.2014.08.016. Epub 2014 Sep 7.
4
Diagnostic and prognostic biomarkers in melanoma.黑色素瘤的诊断和预后生物标志物
J Clin Aesthet Dermatol. 2014 Jun;7(6):13-24.